Hualan Biological Bacterin Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 14.58 million compared to CNY 10.99 million a year ago. Revenue was CNY 14.58 million compared to CNY 10.99 million a year ago. Net loss was CNY 0.849919 million compared to CNY 4.12 million a year ago. Basic loss per share from continuing operations was CNY 0.0023 compared to CNY 0.0115 a year ago. Diluted loss per share from continuing operations was CNY 0.0023 compared to CNY 0.0115 a year ago.